A Phase 1 clinical trial led by researchers at the University of Maryland School of Medicine has demonstrated that a novel ...

Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health have ...

Approved and pre-qualified by the World Health Organization (WHO), the vaccine provides protection for up to five years and ...

Tamil Nadu reports a surge in dengue and typhoid cases with over 16,000 infections. Health officials intensify prevention and ...

Bangladesh has begun a nationwide vaccination campaign to protect millions of children from typhoid, a life-threatening ...

DHAKA, Oct 12, 2025 (BSS) - Director General (DG) of Directorate General of Health Services (DGHS) Professor Dr Md Abu Jafor ...

A novel trivalent vaccine targeting typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has demonstrated promising safety and robust immune responses in a Phase 1 human trial.

A new vaccine against salmonella and typhoid moves closer to approval, according to results of a clinical trial published by researchers at the University of Maryland School of Medicine Oct. 8. “These ...

University of Maryland researchers are developing a vaccine that targets the dangerous foodborne bug, Salmonella.

The team, led by investigators from the University of Maryland (UM) School of Medicine, reported that the trivalent ...